- Home
- MLYS vs BH Comparison
MLYS vs BH Comparison
Compare MLYS & BH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- BH
- Stock Information
- Founded
- MLYS 2019
- BH 1934
- Country
- MLYS United States
- BH United States
- Employees
- MLYS N/A
- BH N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- BH Restaurants
- Sector
- MLYS Health Care
- BH Consumer Discretionary
- Exchange
- MLYS Nasdaq
- BH Nasdaq
- Market Cap
- MLYS 890.6M
- BH 904.4M
- IPO Year
- MLYS 2023
- BH N/A
- Fundamental
- Price
- MLYS $37.16
- BH $316.55
- Analyst Decision
- MLYS Strong Buy
- BH
- Analyst Count
- MLYS 6
- BH 0
- Target Price
- MLYS $42.60
- BH N/A
- AVG Volume (30 Days)
- MLYS 2.6M
- BH 24.1K
- Earning Date
- MLYS 11-10-2025
- BH 11-07-2025
- Dividend Yield
- MLYS N/A
- BH N/A
- EPS Growth
- MLYS N/A
- BH N/A
- EPS
- MLYS N/A
- BH 146.55
- Revenue
- MLYS N/A
- BH $377,176,000.00
- Revenue This Year
- MLYS N/A
- BH N/A
- Revenue Next Year
- MLYS N/A
- BH N/A
- P/E Ratio
- MLYS N/A
- BH $23.99
- Revenue Growth
- MLYS N/A
- BH 4.14
- 52 Week Low
- MLYS $8.24
- BH $159.69
- 52 Week High
- MLYS $39.20
- BH $328.65
- Technical
- Relative Strength Index (RSI)
- MLYS 86.84
- BH 58.22
- Support Level
- MLYS $35.00
- BH $303.46
- Resistance Level
- MLYS $15.79
- BH $317.15
- Average True Range (ATR)
- MLYS 2.50
- BH 10.35
- MACD
- MLYS 2.05
- BH 0.07
- Stochastic Oscillator
- MLYS 91.73
- BH 80.99
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About BH Biglari Holdings Inc. Class B
Biglari Holdings Inc is a holding company that owns subsidiaries in a range of businesses. The company's reportable segments include Restaurant Operations, Insurance Operations, Oil and Gas Operations. Company's restaurant operations include Steak n Shake and Western Sizzlin. Its insurance operations include First Guard, Southern Pioneer, and Biglari Reinsurance. Oil and gas operations include Southern Oil and Abraxas Petroleum. The Company also reports segment information for Maxim. The majority of revenue is derived from the Maxim Segment.